Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today …
Salesforce (NYSE: CRM), the world’s #1 AI CRM, today unveiled two AI-powered innovations for retailers: Agentforce for Retail and Retail Cloud with Modern POS, helping store associates, customer service representatives, and digital merchants boost …
RhyGaze, a biotechnology company based in Basel, Switzerland and Philadelphia, Pa., USA, today announced that it has secured a Series A financing of USD 86 million. The round was led by GV (Google Ventures), alongside Arch Venture Partners, F-Prime Capital …
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the expanded commercial availability of the NavDx test for Molecular Residual Disease (MRD) detection in anal squamous cell carcinoma (ASCC) patients. …
VIPR Solutions (VIPR), a leading provider of Delegated Authority technology, has secured multi-year contracts with three of the most respected and influential insurance brands operating within the UK Lloyd’s Market. This press release features multimedia. …
Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three …
Enveda, a biotechnology company using AI to translate life’s chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 years of biopharmaceutical corporate development and …
Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a leading premium hospitality and live entertainment company built by music fans for music fans, is proud to announce its participation in the iconic New York Stock …
Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624’s novel epigenetic mechanism of action on neurological pathways. The findings provide insights into the potential antidepressant and cognitive …
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) ( …
SIXT USA, a subsidiary of Sixt SE – a global leader in premium mobility services – announces the opening of its newest U.S. location at Louis Armstrong New Orleans International Airport (MSY). The opening marks SIXT’s first branch in Louisiana and expands …
Kardigan, a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. “For decades, …
Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, today announced the expansion of its viral vector service with Packaged on Request. Customers can now select an AAV plasmid from …
WisdomTree, Inc. (NYSE: WT), a global financial innovator, today released monthly metrics for December 2024, including assets under management (AUM) and flow data by asset class. Monthly Commentary: Inflows in U.S. equity and cryptocurrency products, …
Tanger® (NYSE: SKT), a leading owner and operator of outlet and open-air retail shopping destinations, announced today that its financial results for the quarter and year ended December 31, 2024 will be released on Wednesday, February 19, 2025 after the …
The "Aircraft Interiors Market Size, Share, Trend, Forecast Analysis & Growth Opportunity: 2024-2032" report has been added to ResearchAndMarkets.com's offering. The Aircraft Interiors Market was valued at US$ 13 Billion in 2023 and is …
Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. This innovative test is the …
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today highlighted its 2024 accomplishments and announced its anticipated …
The following is a statement from Peter Chapman, Chairman and CEO of IonQ (NYSE: IONQ): Today’s classical computing hardware is limited by computational capacity and power requirements in ways that will likely prohibit society from ever being able to solve …
E2open Parent Holdings, Inc. (NYSE: ETWO) (“e2open” or the “Company”), the connected supply chain SaaS platform with the largest multi-enterprise network, today announced financial results for its fiscal third quarter ended November 30, 2024. “During the …
